高级检索

直肠癌根治术后异时性肿瘤性病变的影响因素

Influencing factors of metachronous tumor lesions after radical resection of rectal cancer

  • 摘要:
    目的 探讨直肠癌(rectal cancer, RC)根治术后发生异时性肿瘤性病变的危险因素。
    方法 回顾性纳入2012年10月至2018年6月在中山大学附属第六医院接受RC根治术的RC患者757例,并根据确诊年龄分为早发性RC组(EO-RC组,<50岁,n=228)和晚发性RC组(AO-RC组,≥50岁,n=529),随访截至2025年3月。收集所有患者一般资料、初始结肠镜及随访结肠镜等相关临床信息。采用Kaplan-Meier(K-M)风险函数比较两组异时性肿瘤性病变的发生风险;采用单因素和多因素Cox比例风险模型分析RC根治术后发生异时性肿瘤性病变的影响因素。
    结果 中位随访时间为30(15, 58)个月。K-M风险函数显示:EO-RC组异时性肿瘤性病变的发生风险明显低于AO-RC组(P<0.001)。多因素Cox比例风险模型结果显示:EO-RC组RC术后异时性肿瘤性病变风险是AO-RC组的50.8%(P<0.001);PIK3CA突变和同时性进展性腺瘤是RC术后异时性肿瘤性病变的独立危险因素(HR=2.360、2.094,P=0.003、P<0.001)。
    结论 发病时高龄、PIK3CA突变和存在同时性进展性腺瘤的RC患者术后易发生异时性肿瘤性病变。早发性RC患者无需频繁的结肠镜监测,临床应考虑对PIK3CA突变和存在同时性进展性腺瘤的RC根治术后患者进行强化监测。

     

    Abstract:
    Objective To explore risk factors for metachronous tumor lesions after radical resection of rectal cancer (RC).
    Methods A retrospective study was conducted on 757 RC patients who underwent RC radical surgery at the Sixth Affiliated Hospital, Sun Yat-sen University from October 2012 to June 2018. The patients were divided into early-onset RC group (EO-RC group, <50 years old, n=228) and average-onset RC group (AO-RC group, ≥ 50 years old, n=529) based on their age of diagnosis, and were followed up until March 2025. General information, initial colonoscopy, follow-up colonoscopy, and other relevant clinical information were collected from all patients. The risk of developing metachronous tumor lesions was compared between two groups using Kaplan Meier (K-M) risk function; univariate and multivariate Cox proportional hazards models were used to analyze the influencing factors of metachronous tumor lesions after RC radical surgery.
    Results The median follow-up time was 30 (15, 58) months. The K-M risk function showed that the risk of developing metachronous tumor lesions in the EO-RC group was significantly lower than that in the AO-RC group (P<0.001). The results of the multivariate Cox proportional hazards model showed that the risk of metachronous tumor lesions after RC surgery in the EO-RC group was 50.8% of that in the AO-RC group (P<0.001); PIK3CA mutation and synchronous advanced adenoma were independent risk factors for metachronous tumor lesions after RC surgery (HR=2.360, 2.094; P=0.003, P<0.001).
    Conclusions RC patients with advanced age, PIK3CA mutations, and synchronous advanced adenomas are prone to developing metachronous tumor lesions after surgery. Patients with EO-RC may not require intensified colonoscopy surveillance postoperatively. However, intensified surveillance strategies should be considered for RC patients harboring PIK3CA mutations or presenting with synchronous advanced adenomas.

     

/

返回文章
返回